CLINICAL_TRIALS
research
· 2025-06-06
Clinical Trial Update: Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients [Phase 1]
Summary
Phase 1 clinical trial evaluating intracoronary administration of OmniMSC-AMI for ST-elevation myocardial infarction is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Bio Therapeutics Inc. | Conditions: Safety Issues | Phase 1 | Status: RECRUITING